CN Patent
CN101244043A — 比伐卢定冻干粉针剂及其制备方法
Assigned to Mudanjiang Youbo Pharmaceutical Co Ltd · Expires 2008-08-20 · 18y expired
What this patent protects
本发明提供一种比伐卢定无菌冻干粉针剂及其制备方法。本发明的比伐卢定无菌冻干粉针剂,其采用碳酸钠或碳酸氢钠调节pH,克服了现有技术中比伐卢定制剂存在的稳定性差的缺陷,产品中活性成分的降解被显著降低,杂质含量低,产品稳定性良好,提高制剂临床应用安全性和有效性。
USPTO Abstract
本发明提供一种比伐卢定无菌冻干粉针剂及其制备方法。本发明的比伐卢定无菌冻干粉针剂,其采用碳酸钠或碳酸氢钠调节pH,克服了现有技术中比伐卢定制剂存在的稳定性差的缺陷,产品中活性成分的降解被显著降低,杂质含量低,产品稳定性良好,提高制剂临床应用安全性和有效性。
Drugs covered by this patent
- Angiomax (BIVALIRUDIN) · Novartis
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.